Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study

被引:23
作者
Geraci, G. [1 ]
Palumbo, V. D. [1 ]
D'Orazio, B. [1 ]
Maffongelli, A. [1 ]
Fazzotta, S. [1 ]
Lo Monte, A., I [1 ]
机构
[1] Univ Teaching Hosp Paolo Giaccone Palermo, Sect Gen & Thorac Surg, Palermo, Italy
来源
CLINICA TERAPEUTICA | 2019年 / 170卷 / 05期
关键词
Diclofenac; ERCP; pancreatitis; complication; prevention; COMPLICATIONS;
D O I
10.7417/CT.2019.2156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Post-Endoscopic Retrograde Cholangio-Pancreatography pancreatitis (PEP) is a relevant (1-4%) complication of biliopancreatic operative endoscopy. Rectal nonsteroidal anti-inflammatory drugs (specifically, 100 mg of diclofenac) have shown promising prophylactic activity in PEP. The aim of our prospective study is to report whether prophylactic oral versus rectal suppository versus intramuscular diclofenac versus placebo are able to reduce the incidence and the severity of ERCP-induced pancreatitis. Materials and Methods. in this randomized, double-blinded, prospective study, 100 patients (49 male, 51 female), similar with regard to indication for ERCP, were enrolled between January 2016 and November 2017 to undergo ERCP in the Section of General and Thoracic Surgery of University Hospital of Palermo. They were randomized into five groups, respectively 20 patients with placebo by mouth; 20 patients with 50 mg diclofenac sodium enteric-coated capsules by mouth; 20 with 100 mg rectal suppository diclofenac, 20 with 75 mg/3 ml intramuscular diclofenac sodium, 20 with 75 mg/3 ml intramuscular diclofenac sodium and 20 with 75 mg/3 ml intravenous diclofenac. All drugs were administered 30 to 90 minutes before ERCP. All clinical data were collected one day before and 2, 12 and 24 hour after ERCP. Results. data were prospectively collected and to demonstrate the preventive effect of rectal diclofenac on PEP, a two-by-two table and chi-square test with Yates correction were used: the incidence of PEP was significantly lower (p < 0.001) in the rectal diclofenac group respect to other groups and, in the same way. the incidence of post-ERCP pain was significantly lower in the rectal diclofenac group than in the other groups (p = 0.001) and patients discharge was consequently earlier (p < 0.01). Conclusions. 100 mg dose rectal diclofenac administered 30-60 minutes before ERCP can effectively prevent PEP.
引用
收藏
页码:E332 / E336
页数:5
相关论文
共 50 条
  • [41] NSAIDs are not enough - a double blinded randomized controlled trial on the impact of intensive hydration for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Carvalho, Pedro Boal
    Magalhaes, Joana
    de Castro, Francisca Dias
    Goncalves, Tiago Curdia
    Monteiro, Sara
    Xavier, Sofia
    Rosa, Bruno
    Cotter, Jose
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (07) : 751 - 756
  • [42] Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis
    Shen, Chongrong
    Shi, Yanqiang
    Liang, Tianyu
    Su, Peizhu
    DIGESTIVE ENDOSCOPY, 2017, 29 (03) : 281 - 290
  • [43] Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials
    Gu, Wan-Jie
    Wei, Chun-Yin
    Yin, Rui-Xing
    NUTRITION JOURNAL, 2013, 12
  • [44] lOral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study
    Lee, Tae Yoon
    Choi, Jung Sik
    Oh, Hyoung-Chul
    Song, Tae Jun
    Do, Jae Hyuk
    Cheon, Young Koog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (05) : 602 - 609
  • [45] Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials
    Xie, Yu
    Cheng, Ziyao
    Deng, Cunliang
    Deng, Mingming
    Zhang, Hailong
    MEDICINE, 2023, 102 (41) : E35174
  • [46] Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis
    Fujita, Koichi
    Yazumi, Shujiro
    Matsumoto, Hisakazu
    Asada, Masanori
    Nebiki, Hiroko
    Matsumoto, Kazuya
    Maruo, Toru
    Takenaka, Mamoru
    Tomoda, Takeshi
    Onoyama, Takumi
    Kurita, Akira
    Ueki, Toshiharu
    Katayama, Toshiro
    Kawamura, Takashi
    Kawamoto, Hirofumi
    DIGESTIVE ENDOSCOPY, 2022, 34 (06) : 1198 - 1204
  • [47] The role of rectal diclofenac and aggressive hydration with Ringer's lactate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients
    Sharma, Vivek Mohan
    Mathur, Amit
    Goyal, Mohan Babu
    Jat, Shankar Lal
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2023, 12 (02): : 87 - 92
  • [48] A Randomized Comparative Study of 24-and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Prospective Randomized Comparison Trial
    Kim, Su Jin
    Kang, Dae Hwan
    Kim, Hyung Wook
    Choi, Cheol Woong
    Park, Su Bum
    Song, Byeong Jun
    Nam, Hyeong Seok
    PANCREAS, 2016, 45 (08) : 1179 - 1183
  • [49] Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials
    Wan-Jie Gu
    Chun-Yin Wei
    Rui-Xing Yin
    Nutrition Journal, 12
  • [50] Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: A prospective, randomized trial
    Park, Ji Young
    Jeon, Tae Joo
    Hwang, Mi Won
    Sinn, Dong Hyun
    Oh, Tae-Hoon
    Shin, Won Chang
    Choi, Won-Choong
    PANCREATOLOGY, 2014, 14 (04) : 263 - 267